ERBB2 and non-small cell lung carcinoma: The mutation rate of HER2 in NSCLC ranges between 1% and 4%, predominantly occurring in non-smokers, females, and lung adenocarcinoma patients5,6, with over 90% presenting as exon 20 insertion mutations, notably Y772_A775YVMA7.